SPDR S&P Biotech ETF
738 hedge funds and large institutions have $8.01B invested in SPDR S&P Biotech ETF in 2023 Q4 according to their latest regulatory filings, with 142 funds opening new positions, 170 increasing their positions, 268 reducing their positions, and 67 closing their positions.
Holders
738
Holders Change
+65
Holders Change %
+9.66%
% of All Funds
10.82%
Holding in Top 10
23
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+35.29%
% of All Funds
0.34%
New
142
Increased
170
Reduced
268
Closed
67
Calls
$2.01B
Puts
$3.26B
Net Calls
-$1.25B
Net Calls Change
-$765M
Top Buyers
Top Sellers
| 1 |
1
Bank of America
Charlotte,
North Carolina
|
$315M |
| 2 |
2
Goldman Sachs
New York
|
$907M |
| 3 |
3
BNP Paribas Financial Markets
Paris,
France
|
$62.7M |
| 4 |
4
Citigroup
New York
|
$367M |
| 5 |
PF
5
Phoenix Financial
Givatayim,
Israel
|
$132M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GTC
826
Ghost Tree Capital
New York
| – | – | – | – |
|
|
FIA
827
FNY Investment Advisers
New York
| – | – | – | – |
|
|
PCM
828
Philosophy Capital Management
Alamo,
California
| – | – | – | – |
|
|
SCM
829
Silverarc Capital Management
Boston,
Massachusetts
| – | – | – | – |
|
|
SCM
830
Soleus Capital Management
Greenwich,
Connecticut
| – | – | – | – |
|
|
ACM
831
Aquilo Capital Management
San Francisco,
California
| – | – | – | – |
|
|
BFM
832
Boothbay Fund Management
New York
| – | – | – | – |
|
|
MCM
833
Masters Capital Management
Atlanta,
Georgia
| – | – | – | – |
|
834
Belvedere Trading
Chicago,
Illinois
| – | – | – | – |
|
|
ECU
835
Eisler Capital (US)
New York
| – | – | – | – |
|
|
PA
836
Perceptive Advisors
New York
| – | – | – | – |
|